Clinical Trial

Systemic Organ Communication in STEMI

Study acronym: SYSTEMI
Recruiting
View on ClinicalTrials.gov →
Summary
Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality. Within the STEMI population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from STEMI patients. This cohort study is an open-end observational study to identify master switches in myocardial ischemia.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-05-25; most recent amendment 2026-01-20.
Trial Details
NCT Number NCT03539133
Lead Sponsor Heinrich-Heine University, Duesseldorf
Conditions ST-segment Elevation Myocardial Infarction (STEMI)
Enrollment 1,000 participants
Start Date 2017-10-18
Primary Completion 2030-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-22